Description
Building on Mirion’s proven iCAM platform, the GA model introduces firmware that disables radon compensation for accurate measurement of high-energy alpha emitters — including Pb-212, Ac-225, and Ra-226. This enhancement supports targeted alpha therapy (TAT) and radiopharmaceutical applications where precise total alpha concentration measurement is critical for regulatory compliance and worker protection – ensuring a comprehensive assessment of airborne radioactivity.
With extended data archiving, fast configuration via iCONFIG software, and compliance to IEC 61172, IEC 60761, and ANSI 42.17B, the iCAM GA offers laboratories and production sites a reliable path to total alpha spectrum monitoring — without compromising continuity or safety.
Configured for Accurate Results
The iCAM GA monitor offers enhanced alpha detection, including radon progeny, enabling direct monitoring of total alpha activity. This ensures accurate detection, improves safety, and supports regulatory compliance in complex isotope-rich settings.
Comprehensive Data Management
Extended data archiving covers operational parameters, including gross alpha by region of interest (ROI) and gross beta short-term and long-term counts, and airflow measurement. Configuration tools and a streamlined interface facilitate fast deployment for uninterrupted monitoring and regulatory compliance.
Performance and Safety
Real-time alerts enable rapid response to potential airborne hazards, while the system’s high sensitivity and detection efficiency ensure reliable performance in demanding environments. iCAM GA sets a new standard for precision, reliability, and confidence in airborne radiological safety.
The iCAM GA is purpose-built to meet the growing use of medical isotopes in targeted alpha therapy (TAT) and other advanced radiopharmaceutical applications.
Applications
Designed for Radiopharmaceutical and Medical Isotope Environments
The iCAM GA is purpose-built for medical isotope monitoring applications, including radiopharmaceutical manufacturing, targeted alpha therapy (TAT) development, and research laboratories. It enables precise airborne alpha detection in complex isotope environments to ensure regulatory compliance and worker safety.
